|
Volumn 10, Issue 8, 2004, Pages 767-768
|
The virtuous virus
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
BEVACIZUMAB;
CAPSID PROTEIN;
CYCLOSPORIN;
HERPESVIRUS VECTOR;
IMMUNOSUPPRESSIVE AGENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
BLADDER CANCER;
CANCER REGRESSION;
CANCER THERAPY;
CELL SURVIVAL;
CELLULAR IMMUNITY;
DNA MODIFICATION;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
GENETIC ENGINEERING;
GLIOBLASTOMA;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
MOLECULAR BIOLOGY;
PRIORITY JOURNAL;
PROMOTER REGION;
PROSTATE CANCER;
PROTEIN EXPRESSION;
RNA VIRUS;
SHORT SURVEY;
VESICULAR STOMATITIS VIRUS;
VIRAL GENE THERAPY;
VIROTHERAPY;
VIRUS;
VIRUS ADSORPTION;
VIRUS ASSEMBLY;
VIRUS PARTICLE;
VIRUS REPLICATION;
VIRUS TYPING;
GENE THERAPY;
GENETIC ENGINEERING;
HUMANS;
IMMUNOTHERAPY;
NEOPLASMS;
VIRUSES;
ADENOVIRIDAE;
ANIMALIA;
HERPESVIRIDAE;
RNA VIRUSES;
VESICULAR STOMATITIS VIRUS;
|
EID: 4043142861
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0804-767 Document Type: Short Survey |
Times cited : (2)
|
References (0)
|